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Abstract 
Piscine orthoreovirus Strain PRV-1 is the causative agent of heart and skeletal muscle inflammation 
(HSMI) in Atlantic salmon (Salmo salar). Given its high prevalence in net pen salmon, debate has arisen 
on whether PRV poses a risk to migratory salmon, especially in British Columbia (BC) where 
commercially important wild Pacific salmon are in decline. Various strains of PRV have been associated 
with diseases in Pacific salmon, including erythrocytic inclusion body syndrome (EIBS), HSMI-like disease, 
and jaundice/anemia in Japan, Norway, Chile and Canada. We examine the developmental pathway of 
HSMI and jaundice/anemia associated with PRV-1 in farmed Atlantic and Chinook (Oncorhynchus 
tshawytscha) salmon in BC, respectively. In situ hybridization localized PRV-1 within developing lesions 
in both diseases. The two diseases showed dissimilar pathological pathways, with inflammatory lesions 
in heart and skeletal muscle in Atlantic salmon, and degenerative-necrotic lesions in kidney and liver in 
Chinook salmon, plausibly explained by differences in PRV load tolerance in red blood cells. Viral 
genome sequencing revealed no consistent differences in PRV-1 variants intimately involved in the 
development of both diseases, suggesting that migratory Chinook salmon may be at more than a 
minimal risk of disease from exposure to the high levels of PRV occurring on salmon farms. 
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Introduction 
Viruses in the species Piscine orthoreovirus (PRV) were first discovered in association with farmed 
Atlantic salmon (Salmo salar) diagnosed with Heart and Skeletal Muscle Inflammation (HSMI) (Palacios 
et al. 2010), although HSMI had been reported within the Norwegian farming industry since 1999 
(Kongtorp et al. 2004a). Even though the disease was infectious (Kongtorp and Taksdal 2009), no virus 
was cultured from affected fish (Kongtorp et al. 2004a,b; Watanabe et al. 2006; Kongtorp and Taksdal 
2009). Moreover, disease challenge studies using viral filtrates from tissue homogenates of Atlantic 
salmon with HSMI (Kongtorp and Taksdal 2009) replicated the patterns of inflammation in heart and 
skeletal tissue that are diagnostic of this disease (Biering and Garseth 2012). However, only recently was 
a cause-and-effect relationship established through a challenge based on an isolate (NOR2012-V3621) of 
Piscine orthoreovirus purified from blood (Wessel et al. 2017), the primary target for the virus (Finstad et 
al. 2014, Wessel et al. 2015).  
Since its discovery in 1999, the prevalence of HSMI has expanded from <30 farms in central Norway to 
hundreds of farms throughout the country (Bornø and Lie Linaker 2015). While HSMI became a 
reportable disease in 2004 (https://lovdata.no/dokument/SF/forskrift/2008-06-17-819), it is no longer 
reportable due both to the ubiquitous distribution of Piscine orthoreovirus (strains of which are 
collectively referred to as PRV) and the large-scale distribution of HSMI outbreaks (Bornø and Lie Linaker 
2015). Moreover, while HSMI was initially reported only in ocean net pens, generally 5 to 9 months post-
stocking (Kongtorp et al. 2004a), there are recent reports of HSMI outbreaks occurring in Norwegian 
freshwater hatcheries (Olsen et al. 2015; Hjeltnes et al. 2016, 2017). HSMI has also been reported in 
farmed Atlantic salmon in Scotland and the United Kingdom (Ferguson et al. 2005), Chile (Bustos et al. 
2011; Godoy et al. 2016) and Canada (Di Cicco et al. 2017).  
While HSMI has been formally diagnosed only in Atlantic salmon, other salmonids and some marine fish 
are also susceptible to infection by PRV (Wiik-Nielsen et al. 2012; Morton et al 2017; Purcell et al. 2018). 
In the last few years, there has been a surge of PRV-related diseases reported in Pacific salmon in 
Norway, Chile, Japan, and Canada (Olsen et al. 2015; Godoy et al. 2016: Takano et al. 2016: Miller et al. 
2017). In addition, outbreaks of a disease designated as ‘HSMI-like’ were reported in farmed Rainbow 
trout (Oncorhynchus mykiss) across five hatcheries and two marine farms in Norway, and a PRV strain 
(variously termed PRVom or PRV-II, most recently classified as PRV-3) was sequenced from affected fish 
(Olsen et al. 2015; Gjevre et al. 2016; Hauge et al. 2017). Challenge studies using tissue homogenates 
from affected Rainbow trout resulted in the development of the pathological lesions, but as with HSMI, 
not the clinical signs (Hauge et al. 2017). However, while inflammatory lesions in the heart and skeletal 
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muscle were present, heart inflammation was more concentrated in the spongy layer. In field outbreaks, 
some clinical signs were similar to HSMI, e.g. anorexia, lethargy, and ascites. Other features of the 
disease were not common in fish with HSMI, notably, anemia, jaundice (yellowish liver), hemosiderosis 
in the spleen, and hemorrhaging that are all consistent with lysis of red blood cells (RBCs). The same 
strain of PRV, and possibly PRV-1, has also been implicated in outbreaks in farmed Chilean Coho salmon 
(Oncorhynchus kisutch), in which major hepatic necrosis and erythrophagocytosis in the kidney and 
spleen were prominent pathological features commonly reported (Godoy et al. 2016).  
Farmed Japanese Coho salmon have also been afflicted by a disease caused by PRV-2, a strain that is 
distinct based on nucleotide sequence from PRV-3 (i.e. the Norwegian PRV-II). The disease associated 
with PRV-2 was named erythrocytic inclusion body syndrome (EIBS) (Michak et al. 1992) where the 
inclusions are due to viral factories in the RBCs, but is highly similar in clinical and pathological signs to 
HSMI-like disease (Takano et al. 2016). Severe anemia and jaundice were hypothesized to be caused by 
excess bilirubin in the liver and a mechanism involving viral mediated lysis of RBCs was suspected (Sakai 
et al. 1994).  
In British Columbia, Canada, the dominant farmed species is Atlantic salmon, while Chinook and Coho 
salmon, both endemic species, currently make up approximately 3% of farmed biomass. A disease 
characterized by jaundice and anemia, also called jaundice syndrome, has caused low level mortality of 
farmed Chinook salmon for several years (Garver et al. 2016), and as observed in Japan, Chile, and 
Norway, the disease is associated with PRV (Miller et al. 2017). In BC, however, only a single strain of 
PRV has been observed, PRV-1. This is the same strain that causes HSMI in Atlantic salmon.  
As a cause and effect relationship has been demonstrated only between Strain PRV-1 and HSMI in 
Atlantic salmon and for Strain PRV-2 and EIBS in Japanese Coho, this study set out to resolve whether 
Strain PRV-1 is likely to play a causative role in the development of jaundice/anemia in BC Chinook 
salmon. This question is relevant to understanding the risk associated with PRV transmission from 
farmed to wild salmon in BC, a topic of interest to the public, government regulators, and industry.  
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Methods 
Farm Samples 
Farmed Chinook and Atlantic salmon were provided by the Fisheries and Ocean Canada (DFO) regulatory 
farm audit program. This program conducts randomized farm audits across the BC salmon aquaculture 
industry (Fig. S1) to assess the role of infectious disease in background losses to production populations 
and to ensure reporting compliance with OIE (World Organization of Animal Health) listed diseases. In 
each farm audit, one to nine fresh silver (recently dead) fish were provided from collections undertaken 
in 2011-2013, with 210 Chinook and 672 Atlantic salmon samples incorporated into our analysis. At the 
time of collection, clinical and environmental data and gross lesions were recorded, and tissue samples 
were taken for histopathology, bacterial and viral culture, as well as molecular analysis. 
Histopathological assessments of audit salmon were provided by Hugh W. Ferguson and veterinary 
diagnostics were provided by Ian Keith (DFO Aquaculture Management Division, Pacific Region).  
The name “jaundice/anemia” assigned to the condition observed in BC Chinook salmon derives from the 
most striking clinical sign (yellowing of the abdomen and under the eye) occurring during the 
development of the disease, with anemia preceding the appearance of jaundice. Chinook salmon were 
classified as “jaundice” if the veterinary diagnostic comments indicated “Jaundice syndrome” or 
“jaundice - no agent”, and/or the gross lesions indicated “yellow fluid” or “yellow bile” or “yellow bile-
like fluid” noted in the peritoneal cavity or on the pyloric caeca and/or liver. As well, two fish with 
pathological notes containing either “(inflammatory) lesions in heart or spongy layer only – CMS-like” or 
“acute renal tubular necrosis, suggestive of viral infection” were classified as “jaundice”, as these are 
also features of jaundice/anemia. Fish were classified as “anemia” if clinical data included the terms 
“anemic” or “pale liver” or “pale gills”.  
While the international standard for diagnosing HSMI (Biering and Garseth 2012) is, at a farm-level, 
based on the presence of inflammatory lesions in heart and skeletal muscle, and not pancreas 
(principally to differentiate HSMI from other virally-mediated heart diseases in Norway), the audit 
sampling program did not include samples of skeletal muscle or pancreas tissue until late 2013. 
However, in a recent publication diagnosing HSMI for the first time on a BC salmon farm (Di Cicco et al. 
2017), our group reported that the viral agents responsible for the other two heart diseases, 
cardiomyopathy syndrome (CMS) and pancreas disease (PD), were not detected in a surveillance of over 
10,000 salmon in British Columbia. Therefore HSMI can be recognized in BC simply on the basis of 
virally-mediated myocarditis lesions in the heart. Hence, Atlantic salmon in this study were diagnosed 
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with “HSMI” if the histopathology notes indicated “CMS/HSMI-like”, or “CMS-like myocarditis”, or 
“(inflammatory) heart lesions look to be viral”, or “severe viral-type myocarditis/pericarditis”, or 
“(inflammatory) heart lesions affecting compact layer”.  
A longitudinal collection of Atlantic salmon from a single farm outbreak of HSMI (Di Cicco et al. 2017) 
was also utilized in our analyses, providing a means to finely study the disease development pathway of 
HSMI in a single population. These collections included sampling of live and moribund/recently dead fish 
from a single farm in the Discovery Islands over the 11 month course of the disease outbreak. The 
pathological investigation showing the development of inflammatory lesions in both heart and skeletal 
muscle tissues within these sampled fish over time is already described (Di Cicco et al. 2017), and we 
used the classification of fish along the disease development pathway outlined in that study to identify 
individuals upon which to attempt the localization of PRV through in situ hybridization (ISH) analysis.  
 
Molecular Analyses 
Samples for molecular analysis were collected through dissections on the farms, where live-sampled fish 
were killed by industry personnel by stunning (a blow to the head), as is the industry standard for food 
fish. For the longitudinal sampling, brain, liver, gill, kidney, and heart were sampled and preserved 
separately in RNA-later, held at 4oC for 24 hours before being transferred into a -80oC freezer until 
nucleic acid extraction. Audit tissue samples also included spleen and pyloric caeca, with skeletal muscle 
and pancreas added to a small portion of the samples in 2013; audit tissue samples were kept on ice 
until reaching the laboratory by the end of the day and then frozen at -80oC in a single sterile tube. DNA 
and RNA were extracted from combined Tri-reagentTM homogenates of all collected tissues for the audit 
samples, and solely the heart tissue for the HSMI longitudinal study, using methods described previously 
(Miller et al. 2016).  
We employed the Fluidigm BioMarkTM HD microfluidics quantitative PCR platform to assess the presence 
and load of 45 salmon infectious agents, including viruses, bacteria, fungi and protozoan parasites for 
Atlantic salmon in the longitudinal study (Di Cicco et al. 2017) and for farm audit salmon (Miller et al. 
2017). Viruses with TaqMan assays included in this analysis: PRV, Atlantic salmon paramyxovirus (ASPV), 
Infectious hematopoietic necrosis virus (IHNV), Infectious salmon anemia virus (ISAV), Pacific salmon 
parvovirus (PSPV), Piscine myocarditis virus (PMCV), Salmonid alphavirus (SAV), Salmonid herpesvirus 
(OMV), Encephalopathy and retinopathy virus (VER), Erythrocytic necrosis virus (ENV), and Viral 
hemorrhagic septicemia virus (VHSV). Details on the analytical performance of these and other 
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infectious agent assays on the platform were evaluated previously (Miller et al. 2016), in which the 
sensitivity (limit of detection), repeatability, and specificity of each assay are shown. To limit false 
positive amplification, all laboratory processing steps were carried out in dedicated workspaces, most in 
UV hoods, separating pre- and post-amplification procedures into different laboratories and adding 
artificial construct positive controls last, as described in Miller et al. (2016). 
A panel of host biomarkers (genes) that when co-expressed identifies fish in a viral disease state (VDD) 
was developed and validated (Miller et al. 2017), where their application to the salmon audit samples 
using the Fluidigm BioMark platform was also described. The original panel evaluated by Miller et al. 
(2017) included TaqMan assays to 51 biomarkers, 20 of which had good efficiencies and provided viral 
disease resolution in Chinook salmon, and 22 in Atlantic salmon (Table S1). However, in the 2017 paper, 
we showed that as few as 11 biomarkers were required to differentiate fish merely carrying a virus from 
those experiencing cellular-level expression of a viral disease (and sensitive to the early phase of 
disease, when histopathological changes are not yet visible), which was the application of interest for 
this study. Moreover, we showed that the VDD signature was predictive of viral disease regardless of the 
tissue assessed, and as such, worked equally well on the multi-tissue RNA samples from the audit 
program as opposed to single tissue (heart) analysis. 
We applied the VDD panel to the audit fish in order to resolve early disease development associated 
with PRV in both Atlantic and Chinook salmon, and to differentiate fish that were simply carriers of the 
virus from those that were actually in a viral disease state. The panel was applied to all of the fish in our 
collections, hence also included fish for which PRV was not detected, and could potentially contain other 
viral-mediated diseases. Herein, we restrict most of our presentation, and all of our ISH analyses (except 
for controls), to fish that contained PRV at loads >103 copies per µg nucleic acids (with one exception; 
most >104 copies per µg), although we calculate prevalence of a viral disease state in sampled farmed 
salmon. 
Host biomarkers in the VDD panel were normalized to three reference genes derived from previous 
microarray studies (Table S1), and relative gene expression was assessed using the 2-ΔΔCt method (Livak 
and Schmittgen 2001). A pooled sample was used as the relative control. Classification of fish in a viral 
disease state was conducted through principle components analysis (PCA) of the expression data from 
20 assays in Chinook and 22 assays in Atlantic salmon using the sample scores across PC1, as described 
by Miller et al. (2017). The goal of the VDD classification was to identify PRV-positive fish that may be in 
an early viral disease state, but not specifically diagnosed through pathology or clinical signs with a PRV-
related disease. Hence, the edge of the VDD signature was determined by PC1 sample scores within the 
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range of fish identified in a viral disease state (jaundice/anemia for Chinook and HSMI for Atlantic). A 
species-specific VDD threshold was chosen at the maximum value of Youden’s J statistic for a ROC 
analysis of the PC1 sample scores, where viral disease state (identified/not identified) was used as the 
binary class for the ROC analysis. The Youden’s J statistic represents the value of (sensitivity + specificity 
-1) for each point on the ROC curve and takes on values in [-1,1], with 1 characterizing a perfect test 
where sensitivity and specificity are both at 100. This approach optimizes the differentiating ability of 
the classifier when equal weight is given to sensitivity and specificity (Youden 1950).  
 
Sample selection for ISH 
The goal of our ISH study was to track the movement of PRV within salmon tissues during early 
infection, development and peak states of disease development in Atlantic and Chinook salmon. To 
study HSMI in Atlantic salmon, we selected twenty four samples collected from the longitudinal study 
that diagnosed HSMI in British Columbia (Di Cicco et al. 2017) which had already been analyzed through 
histopathology and scored for heart and skeletal muscle lesions consistent with HSMI (see score system 
in Di Cicco et al. 2017). Following the indications of the previous analysis, we identified three stages of 
disease development, and conducted ISH analysis on six fish per stage. The stages were classified as: 
1. Fish negative to PRV, and showing no histopathological lesions in any organ; negative control 
fish 
2. Fish positive to PRV (>103 copies per µg nucleic acids), and showing no histopathological lesion 
in any organ (heart score = 0); “initial” stage of infection 
3. Fish positive to PRV (>103copies per µg with one exception), showing mild degree lesions in the 
heart consistent with HSMI, but primarily localized in the epicardium and the compact layer of 
the myocardium (heart score = 1.5 to 3); “developing” stage of infection 
4. Fish positive to PRV (>103-copies per µg), showing severe lesions in the whole heart 
(panmyocarditis) diagnostic of HSMI (heart score ≥4); “HSMI” 
The samples chosen for ISH analysis consisted primarily of live, apparently healthy/asymptomatic fish 
for the first three groups, and moribund/freshly dead fish for the HSMI group. 
Samples potentially representing different stages of development of jaundice/anemia in Chinook salmon 
were chosen on the basis of 1) PRV load (>104 copies per µg nucleic acids, with one exception), 2) VDD 
classification, and 3) whether fish had been diagnosed with jaundice/anemia. From these data, we 
selected three groups of samples: 
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1. Fish positive for PRV (>103 copies per µg), but VDD negative ; “PRV+ only” (three samples) 
2. Fish positive for PRV (>103 copies per µg) and classified as in a VDD state; “PRV+/VDD+” (five 
samples) 
3. Fish positive for PRV (>103 copies per µg), in a VDD state and diagnosed with jaundice (most 
also with anemia); “jaundice/anemia” (nine samples) 
All audit Chinook samples were moribund/recently dead. No fish in group 1 and 2 showed signs of 
jaundice and only one fish in group 2 showed signs of anemia (but no jaundice). 
 
Histopathology 
Preparation of the tissues for histopathological evaluation has been described previously (Di Cicco et al. 
2017). Briefly, all tissues fixed in 10% neutral buffered formalin were dehydrated through an ascending 
gradient of alcohol solutions, embedded in paraffin wax, cut at 3.5μm thickness and stained with routine 
hematoxylin and eosin (H&E) for morphological evaluation by light microscope.  
For both Atlantic and Chinook salmon, histology slides contained a section of heart (atrium and 
ventricle), liver, anterior and posterior kidney, spleen, intestine (often both small intestine and colon), 
skeletal muscle, brain and gills. All samples were read and scored by two pathologists (HWF and ED), 
with exception of group 1, 2 and 3 of the HSMI study which were read principally by one pathologist 
(ED). The scoring system for heart and skeletal muscle lesions were as described (Di Cicco et al. 2017), 
and followed Finstad et al. (2012). For the other organs, we utilized the scoring system used for 
regulatory purposes in the audit program. The severity of lesions was classified as 0 (no lesion), 1 (mild 
lesion), 2 (moderate lesion) and 3 (severe lesion). Consecutive slides from the same fish were cut for ISH 
to allow comparison between the presence of histopathological lesions and the localization of PRV. 
Statistical evaluation of histopathology scores was undertaken to identify lesions showing the strongest 
inter-species differences. Principle components analysis was applied to the lesion scores to identify the 
main trajectories in the data and visualize whether Atlantic and Chinook salmon clustered separately. A 
PCA biplot was used for visualization to project the lesions onto the same graph as the samples (Ringnér 
2008; Gabriel 1971). As well, lesion scores were treated as binary variables (zero score vs positive score) 
and contrasted between species for each of the three groups with PRV detections. Barnard’s (exact) test 
was used to identify lesions that were significantly different between species (Barnard 1945). The 
analysis was implemented in R version 3.3.2 based on the ‘Exact’ package (version 1.7). 
 
In Situ Hybridization (ISH) 
Accepted for publication in FACETS on 23 April 2018, DOI 10.1139/facets-2018-0008 
10 
 
RNA-ISH was performed using BASEscope (RED) (Advanced Cell Diagnostics, Newark, CA) according to 
the manufacturer’s instructions. Briefly, consecutive sections of all Atlantic and Chinook salmon samples 
utilized for the histopathological analysis were dewaxed by incubating for 60 min at 60°C and 
endogenous peroxidases were quenched with hydrogen peroxide for 10 min at room temperature. 
Slides were then boiled for 30 min in RNAscope Target Retrieval Reagents and incubated for 30 min in 
RNAscope Protease IV reagent prior to hybridization. The slides underwent hybridization with a 
BASEscope probe against a portion of PRV-1 genome segment L1 (that codes for PRV core shell ; 
Advanced Cell Diagnostics, catalog #705151), in order to detect PRV in the tissues. A BASEscope probe 
against the bacterial gene dapB (#701021) was used as negative control to confirm absence of 
background and/or non-specific cross-reactivity of the assay. Concurrently, PRV/HSMI positive (n = 2) 
and negative (n = 1) heart samples from Atlantic salmon collected during an experimental challenge for 
HSMI performed in Norway (Finstad et al. 2014) were used as positive and negative controls for PRV-1 
presence and localization. Signal amplification was performed according to the manufacturer’s 
instructions, followed by counterstaining with Gill’s hematoxylin and visualization by bright field 
microscopy. 
 
Immunohistochemistry with antibody to hemoglobin  
To evaluate the presence of hemoglobin in the damaged tissues of Chinook salmon, an antibody raised 
against hemoglobin (rabbit polyclonal Anti-Hemoglobin subunit beta antibody, ab202399, Abcam Inc., 
Toronto, Canada) was utilized to perform immunohistochemistry on a subset of samples of Chinook 
salmon (affected by various degrees of renal tubular necrosis – n=3 fish classified as “PRV+/VDD+” and 
n=3 samples from fish diagnosed with jaundice/anemia ) and fish presenting no lesions in the kidney 
(n=2 fish classified as “PRV+ only” ). The protocol was previously described (Di Cicco et al. 2017). Briefly, 
3.5 µm thick paraffin wax embedded sections were mounted on Superfrost Plus glass slides (Thermo 
Fisher Scientific, Portsmouth, USA). These were heated at 60 °C for 20 min, dewaxed in xylene and 
rehydrated through graded alcohols. Antigen retrieval was performed by autoclave treatment (121 °C 
for 10 min) in citrate buffer (0.1 M, pH 6.0). The sections were successively treated with 3% hydrogen 
peroxide for 1h to block endogenous peroxidase activity. Non-specific binding sites were blocked by 
normal goat serum (Vector Laboratories, Burlingame, CA, USA) diluted 1:10 in 1% bovine serum albumin 
(Vector Laboratories, Burlingame, CA, USA) in TBS [pH 7.6, 0.05 M Tris/HCl, 0.15 M NaCl] for 1h. The 
same diluent solution was used for primary antibodies (1:100) and then incubated in a humidity 
chamber at 4 °C overnight. A Vectastain ABC-peroxidase kit (Vector Laboratories, Burlingame, CA, USA) 
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was used for detection of bound antibody according to the manufacturer’s instructions, and ImmPACT 
NovaRED (Vector Laboratories, Burlingame, CA, USA) was utilized as substrate. Finally, the sections were 
counterstained with Harris’ hematoxylin and mounted (Permount). All incubations, except with the 
primary antibodies, were carried out at room temperature in a humidity chamber. Two PRV negative 
samples (including all internal organs and not showing histopathological signs of hemolysis and/or 
anemia) were used as negative control. Primary and secondary antibody controls were performed by 
replacing the antibody with the respective diluent alone. 
 
Whole genome sequencing of PRV 
RNA viruses exist as groups of closely related genotypes, known as a viral quasispecies. These can exist 
as several master variants, each with their own cloud of mutants (Lauring and Andino 2010; Mordecai et 
al. 2016). Dhamotharan et al. (2018) recently showed that there are currently 3 strains of PRV, known as 
PRV-1, 2 and 3, which they described as variants of PRV. However, in order to accurately describe the 
variation found within these three groups, the nomenclature needs to be refined. In this manuscript we 
refer to PRV-1, 2 and 3 as strains (i.e. master variants). Finally, we refer to each unique consensus 
sequence (itself made up of individual sequencing reads from different individual virions) as a sequence 
variant.  
While we know from previous studies that currently only Strain PRV-1 has been observed in British 
Columbia, we conducted whole viral genome sequencing in individuals across farm audits with fish 
diagnosed with HSMI (Atlantic salmon; 6 farms) or jaundice/anemia (Chinook salmon; 4 farms). For 
Chinook salmon, we also sequenced three individuals from farms with nearly all fish collected classified 
as PRV+/VDD+. This information is critical to determine if there were any consistent differences in the 
sequence of the virus associated with each disease, and consequently indicate the potential risk of 
disease transmission from farmed Atlantic to wild Pacific salmon.  
For each farm audit, we sequenced the fish carrying the highest load of PRV (with one exception). We 
made every attempt to represent disease occurrence broadly distributed over the farming region in 
British Columbia, as dictated by the 2011 to 2013 audit samples provided to us. For Atlantic salmon, 
farms were located along the inside passage of Vancouver Island (Discovery Islands [Regulatory area 
A3.2]) and Broughton Archipelago [A3.3] and the Central Coast [A3.5] (Fig. S1). These audit collections 
spanned three seasons, represented three companies, included samples from 2011, 2012 and 2013, and 
included two collections from the same farm over successive seasons within the same year. For Chinook 
salmon, four farms were on the west coast of BC [P2], and three were located in the Discovery 
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Island/Broughton Archipelago region [P3] (see locations on Fig. S1). These audit collections spanned 
three seasons, represented four companies, included samples from 2011, 2012 and 2013, and included 
sampling from the same site and season collection over two separate years. 
Because loads of PRV were very high for Chinook salmon (> 105 copies/µg nucleic acids), we carried out 
RNA-sequencing with no enrichment, as described by Di Cicco et al. (2017). However, previous studies in 
our lab have suggested that full genome sequences were not guaranteed at loads < 105 copies/µg 
nucleic acids, which was the case for most of the Atlantic salmon samples. Hence, we included a Sure-
SelectTM (Agilent, Santa Clara, CA) enrichment step for viral content (our Sure Select panel includes 
oligos across the full genomes of PRV-1 as well as many other salmonid viruses assessed on our 
infectious agent monitoring platform).  
The Atlantic salmon samples were prepared using the SureSelectXT RNA Direct NGS target workflow 
(Agilent, Santa Clara, CA). This included preparing the RNAseq library with the SureSelect Strand-Specific 
RNA library Prep kit (Agilent, Santa Clara, CA) according to manufacturer’s instructions. The adaptor 
ligated samples were purified with the Agencourt AMPure XP system (Beckman Coulter, Brea, CA). HS 
DNA chips were run on the Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) to determine the final 
library size and the Qubit dsDNA HS kit (Invitrogen, Carlsbad, CA) was used to determine the 
concentration. Vacuum centrifugation (30oC/20’) was necessary to obtain 200ng of the adapted libraries 
in the appropriate volume for hybridization. Hybridization of the adapted cDNA library with the viral 
SureSelect bait capture library (Agilent, Santa Clara, CA ) was performed at 65oC for 24hrs, according to 
manufacturer’s instructions. The cDNA library/capture library hybrids were captured on streptavidin 
magnetic beads and purified with the Agencourt AMPure XP system (Beckman Coulter, Brea, CA). Index 
tags were added to the post captured libraries through 15 rounds of amplification and purified using the 
Agencourt AMPure XP system (Beckman Coulter, Brea, CA). HS DNA chips were run on the Agilent 2100 
Bioanalyzer (Agilent, Santa Clara, CA) to determine the final library size and the concentration was 
determined using the Qubit dsDNA HS kit (Invitrogen, Carlsbad, CA). Sample libraries were normalized to 
4nM, and denatured and diluted to obtain a final library of 20pM. The Atlantic salmon enriched RNAseq 
libraries were processed on 1 paired end v2 300bp kit on the Illumina MiSeq System (Illumina, San 
Diego, CA), which included a 10% phiX spike in.  
For the Chinook salmon RNA-seq, ribosomal removal was performed using the Epicentre ScriptSeq 
Complete Gold Kit (Epidemiology) (Illumina, San Diego, CA) according to manufacturer’s instructions. A 
Zymo RNA Clean and Concentrate-5 kit (Zymo Research, Irvine, CA) was applied to purify the rRNA 
depleted total RNA, according to manufacturer’s instructions, and quantified using the Qubit RNA HS kit 
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(Invitrogen, Carlsbad, CA). ScriptSeq Index reverse primers were added to the cDNA during the final 
amplification step, which involved 14 cycles. The Agencourt AMPure XP system (Beckman Coulter, Brea, 
CA) was applied to purify the 3’-terminal tagged cDNA and final amplified library. HS DNA chips were run 
on the Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) to determine the final library size and the 
concentration was determined using the Qubit dsDNA HS kit (Invitrogen, Carlsbad, CA). Sample libraries 
were normalized to 4nM, and denatured and diluted to obtain a final library of 20pM. The Chinook RNA-
seq libraries were run over 2 paired end v3 600bp reagent kits on the Illumina MiSeq System (Illumina, 
San Diego, CA), which included a 2% phiX spike in.  
 
PRV Genome Sequence Analysis 
The quality of the raw reads was checked using FASTQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Low quality reads or regions of reads 
and adapter sequences were removed using Trimmomatic (Bolger et al. 2014). The remaining reads 
were aligned to the PRV genome segments of the Norwegian isolate Salmo/GP-2010/NOR (Palacios et al. 
2010) using the BWA-mem aligner with default parameters. A consensus sequence of the aligned reads 
was created within Geneious (V10.1.3) using a threshold of 95%. The consensus sequences were then 
aligned using Muscle (within Geneious), and trimmed to the shortest resulting contiguous sequence. 
Trees were constructed using the MrBayes plug in within Geneious. 
 
Results 
VDD classification in audit salmon 
Atlantic salmon 
In farm audit data, HSMI was diagnosed across multiple individuals on four farms, with one farm 
showing evidence of HSMI in two year-classes. In all, 17 fish were specifically diagnosed with HSMI. In 11 
of the HSMI fish, copy number of PRV in the mixed tissue sample was between 104-105 per µg nucleic 
acids, but in six fish, it was <104. In all but two cases where PRV values were <104 but fish were 
diagnosed with HSMI, there were other fish on the same farm with HSMI with higher copy numbers of 
PRV. In one case, the fish was characterized with “Mild CMS-like lesions” and all other fish on the farm 
carried higher copy numbers of PRV. In the other case, a single fish was characterized as “Heart lesions 
are viral-like (CMS/HSMI)”, but no PRV detection was observed on the farm; we suspect this was not an 
HSMI fish.  
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Principle components analysis (PCA) was applied to differentiate fish in a viral disease state based on the 
application of the VDD biomarker panel. One outlier fish with a rotational value of -24 was removed 
from the analysis. 90% of fish with PRV loads > 105 and all but one fish diagnosed with HSMI had 
rotational values <0 (Fig. 1a). We established a VDD threshold at the point where the maximum of 
Youden’s J statistic was observed for a ROC analysis of the rotational values, with HSMI disease vs no 
disease as the two classes. This approach optimized the differentiating ability of a HSMI classifier with 
equal weight given to sensitivity and specificity. This resulted in a VDD threshold at a rotational value of 
-2.42. At this threshold, 89% of Atlantic salmon with PRV copy number per µg nucleic acids between 105-
106 (19 fish) and 49% of fish between 103-105 (70 fish) classified as VDD+ (Fig. 1c). 15% of fish with PRV 
loads exceeding 103 classifying as VDD+ were diagnosed with HSMI. In all, 31% of 670 Atlantic salmon 
audit fish with biomarker data available were classified as VDD+; 43% of VDD+ fish contained multi-
tissue PRV copy numbers exceeding 103, 25% > 104, and 9% >105. Only 16% of fish not classifying as 
VDD+ carried PRV exceeding 103 and 5% exceeding 104 copies per µg nucleic acids.  
At a farm-level, the PRV-VDD classification revealed an additional 15 farms with multiple fish classified 
as PRV-VDD and 2 farm audits that had a single fish diagnosed with HSMI had at least one additional fish 
classifying as PRV-VDD; the outlier HSMI fish not in a VDD state was on one of these farms. In total, 20 of 
the 165 (12.1%) Atlantic salmon farm audits (excluding 38 audits with only a single fish sampled) carried 
farm-level evidence of HSMI or PRV-VDD, or both.  
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Fig. 1. Principle components analysis (a,b), and bean plots of the distribution of PRV productivity (log10 copy 
number) for VDD/no VDD groups (c,d) for viral disease development panels applied to farmed Atlantic salmon on 
the left (a,c) and Chinook salmon on the right (b,d). Principal component analysis show samples colored according 
to load of PRV with disease-diagnosed fish circled in black. The vertical line indicates the VDD threshold as 
determined by Youden's J statistic. Polygons in the bean plots represent non-parametric density estimates, white 
bars show total samples corresponding to log10 copy numbers, solid black bars represent the median log10 copy 
number in the middle plots, and mean log10 copy numbers in the bottom plots. The dotted line in the middle plots 
marks the overall median log10 copy number. 
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Chinook salmon 
There was evidence of jaundice/anemia across most, if not all collected samples in two of the Chinook 
salmon farm audits, with two additional farms containing single fish diagnosed with jaundice/anemia. In 
all, 13 Chinook salmon contained the clinical signs of jaundice/anemia and one fish only had clinical signs 
of anemia, but was from one of the farms with jaundice/anemia fish, and hence was reclassified as a 
jaundice/anemia fish (likely at an early stage of disease development); PRV copy number exceeded 104 
copies per µg nucleic acids in all but one of these fish.  
All but one of the 14 Chinook salmon diagnosed with jaundice/anemia (and one with only anemia) 
clustered on the negative end of the PC1 distribution, with rotational values <-7.33; this was the VDD 
threshold determined the same way as for Atlantic salmon based on Youden’s J statistic (Fig. 1b). There 
was a stronger threshold response in Chinook salmon to high PRV copy number, with 100% of fish with 
copy numbers exceeding 106 (8 fish) and 93% from 105-106 (14 fish) classifying as VDD+ (Fig. 1d). Only 
29% of Chinook salmon with PRV copy number between 102 and 103 (28 fish) classified as VDD+. Over all 
Chinook salmon audit fish, 27% of fish with biomarker data classified as VDD+, with 46% of these 
associated with high loads of PRV (>104). 45% of PRV-VDD fish were diagnosed with jaundice/anemia.  
At a farm-level, in both farms with singleton fish diagnosed with jaundice/anemia, additional fish 
sampled on the farm were classified as PRV-VDD. Three additional farms contained multiple fish 
classified as PRV-VDD. In total, 6 of 34 (17.6%) of farm audits with more than one fish sampled carried 
farm-level evidence of jaundice/anemia or PRV-VDD, or both.  
 
Infectious agent monitoring 
Atlantic salmon 
Samples chosen for histopathology and ISH analysis of fish during an HSMI outbreak in Atlantic salmon 
(longitudinal study) were assessed for presence and load of 45 infectious agents in heart only. Only two 
agents other than PRV were present in some of the fish, both parasites, and neither correlated with 
developing heart lesions (presented by Di Cicco et al. (2017)). Kudoa thyrsites was detected in a portion 
of fish in all groups, with highest loads observed in two of the control (group 1) fish (Table 1). 
Desmozoon lepeoptherii (aka Paranucleospora theridion) was observed in all fish, with similar load 
distributions in each group. 
Chinook salmon 
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Agent distributions were more complex in the multi-tissue audit samples of Chinook salmon (Table 2). 
Recognizing that all of these fish were collected as moribund or recently dead, unlike the primarily live-
sampled fish analyzed in the HSMI outbreak, they carried a larger range of agents, some with 
pathological changes suggesting mixed infections (Table 3). Single instances of rickettsiosis, bacterial 
kidney disease, vibriosis, aspecific branchitis and Loma infection were diagnosed and verified by the 
presence of the causative pathogens (at high load). Two of these individuals were in group 1 
(PRV+/VDD-), while the remainder were in group 2 (PRV+/VDD+). In one instance, while rickettsiosis was 
a differential, no P. salmonis was observed (772). The only virus that was observed other than PRV was 
an occasional detection of the DNA virus ENV. Miller et al. (2017) showed that the VDD panel was not 
stimulated in response to the presence of ENV, and as it was designed only with transcriptome data for 
RNA viruses, we speculated that it would not identify a DNA viral disease state; however this will need to 
be confirmed by further analysis. Hence, while three individuals classified as jaundice/anemia contained 
high loads of ENV, ENV was unlikely to have contributed to their molecular classification. Moreover, t-
tests to assess whether any infectious agent(s) other than PRV were statistically associated with 
jaundice/anemia revealed no significant results.    
 
Histopathology and ISH 
The scoring of heart lesions diagnostic of HSMI in Atlantic salmon is presented in Table 1. The type and 
severity of histopathological lesions reported are shown across all tissues in Atlantic salmon during the 
course of an HSMI outbreak and Chinook salmon during the development of jaundice/anemia in Table 3. 
Note that while we were able to provide a quantitative score (0-3) for each pathological lesion, due to 
the large number of different cell types positively marked by ISH (i.e. infected by PRV) that appeared to 
be involved in the pathogenesis of the two diseases, and the different amount and size of positive dots 
observed in the cells (indicating a different quantity of viral particles, incomplete particles and viral 
transcripts in a determined area), we carried out only a qualitative assessment of PRV presence, 
localization and quantity, to describe where the virus was located during the different stages of 
development of the two diseases.  
Below, we provide a description of the disease development process within each of these diseases and 
the localization of PRV through ISH. 
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Atlantic salmon 
Overall, in the longitudinal study, we did not observe any variation in the quality of PRV staining 
between  live, moribund and recently dead individuals, suggesting that variation in tissue quality 
between species (Chinook were all moribund/recently dead) is not likely to impact our findings. 
Blood: PRV was detected in RBCs from all fish with molecular detection of PRV, and none where PRV 
was not detected by qPCR. The marking was characterized by several dots of various sizes inside the 
cytoplasm of the cells (Fig. 2a). In some cases, the dots were so numerous they filled the entire 
cytoplasm of the RBCs. The marking in the RBCs was particularly evident in fish at the initial phase of 
infection, while those classified as “developing” or “HSMI” showed, overall, a slight decrease of marking. 
Heart: No lesions were reported in the heart of fish that did not carry PRV or those in the initial phase of 
the infection with high loads of PRV (Fig. 3a). PRV marking was predominantly localized in several RBCs 
of the blood circulating inside the organ in the initial phase of infection (Fig. 3b), while rare, scattered 
dots were observed in few cardiomyocytes in two of six fish. All fish classified as “developing lesions” 
showed mild to moderate inflammation primarily involving the epicardium, but a few inflammatory foci 
were also present in the compact layer and, to a minor extent, in the spongy layer of the myocardium 
(Fig. 3c, 4a and 4c). In these samples, PRV marking was observed in a few endothelial cells from small 
vessels as well as nearby cardiomyocytes in both compact and spongy layers of the myocardium. These 
areas of PRV-infected cardiomyocytes were often associated with small aggregates of lymphocytes and 
macrophages, although several infected cardiomyocytes were also scattered in the tissue, with no 
associated inflammatory reaction (Fig. 3d, 4b and 4d). The marking of cardiomyocytes was characterized 
by several dots of various sizes distributed inside the cytoplasm of the cells. Fish diagnosed with HSMI 
had extensive inflammation in the heart, involving epicardium, both layers of the ventricular 
myocardium, and in some instances, the atrium (i.e. panmyocarditis) (Fig. 3e and 4e). The inflammation 
was morphologically characterized by the infiltration of lymphocytes and macrophages, and was 
associated with scattered endocardial hypertrophy and intercellular edema (between endocardial and 
myocardial cells, and in particular in the spongy myocardium, when severely inflamed) and focal areas of 
myocardial degeneration indicated by loss of striation and hypertrophic cardiomyocytes as signal of 
damage reparation. In HSMI fish, PRV was widely distributed in most of the cardiomyocytes of the 
compact layer, but several extended areas of the spongy myocardium were also heavily marked (Fig. 3f 
and 4f). At times, the dots in the cardiomyocytes were so numerous as to basically fill the whole 
cytoplasm of the cells. Severe, extensive inflammatory infiltrates were associated with the PRV-infected 
areas. 
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Liver: Fish not diagnosed with HSMI showed no apparent lesions in the liver, with the exception of rare, 
small, and scattered hepatocellular necrotic foci in fish classified as “developing” (Fig. 5a and 5c). PRV-
marking was confined to RBCs in fish in the initial phase of the infection (Fig. 5b). In the “developing” 
phase, several hepatocytes were also infected with PRV (Fig. 5d), with marking dots of various sizes and 
number distributed inside the cytoplasm of the cells. All fish diagnosed with HSMI presented widespread 
areas of moderate hepatocellular necrosis, with the typical distribution pattern occurring in a “heart 
failure” condition (i.e. zonal necrosis primarily localized around the central veins, which represent the 
farthest areas of the liver parenchyma from oxygenated blood) (Fig. 5e); the number of positively 
marked hepatocytes was slightly reduced in HSMI fish, but still present in several cells (Fig. 5f). 
Kidney: No necrotic lesions were reported in the kidney from any of the groups (Fig. 6a). However, fish 
classified in the “developing” phase of HSMI and fish diagnosed with HSMI presented with some cases 
(2/6 and 3/6, respectively) of mild interstitial hyperplasia, and an increased number of leucocytes in the 
blood vessels (Fig. 6c and 6e). PRV was detected in several RBCs in the kidney, but also in a few 
macrophages and melanomacrophages scattered through the hemopoietic tissue in fish in the initial 
phase of infection (Fig. 6b), although the number of macrophages positive to PRV marking was notably 
higher in two of the six fish. In fish classified as “developing”, the number of macrophages and 
melanomacrophages positive for PRV increased considerably, particularly around the kidney tubules 
(Fig. 6d), and slightly decreased in fish with HSMI (Fig. 6f). 
Spleen: No lesions were observed in the spleen of fish that were PRV negative or in the initial phase of 
infection (Fig. 7a). In the initial phase, PRV was present in several RBCs and in fewer reticular cells of the 
ellipsoids and around the sinusoids (Fig. 7b). In fish classified as “developing” and fish diagnosed with 
HSMI, mild white pulp hyperplasia was reported (2/6 and 3/6, respectively) (Fig. 7c). All fish with HSMI 
also had mild to severe ellipsoid necrosis, with loss of reticulin framework, and mild to moderate 
congestion in 4 of 6 fish (Fig. 7e). The number of PRV-infected RBCs increased substantially (highlighting 
the localization in the parenchyma of the sinusoids, which appeared full of RBCs) in fish classified as 
“developing” and was associated with an increase in PRV-positive macrophages around the sinusoids 
(Fig. 7d); this pattern was slightly decreased in fish with HSMI (Fig. 7f). 
Intestine: No lesions in the intestine were observed in any of the four groups (Fig. S2a, 2c and 2e). 
Positively marked RBCs were observed in all fish with molecular detection of PRV (Fig. S2b), but several 
enterocytes were also marked in fish classified as “developing” (Fig. S2d). The number of PRV positive 
enterocytes was considerably lower in fish with HSMI (Fig. S2f), and the marking was characterized by a 
few small dots scattered in the cytoplasm of the enterocytes. 
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Fig. 2. a) Blood clot in Atlantic salmon with no evidence of lesions. Several PRV particles (red – arrows) are visible 
in numerous RBCs (some of which are defined by the dotted circles). ISH (scale bar 20μm). b) Blood clot in Chinook 
salmon with no evidence of VDD or lesions. Several PRV particles (red – arrows) are visible in numerous RBCs 
(some of which are defined by the dotted circles). ISH (scale bar 20μm).  
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Fig. 3. Histopathology and ISH in Atlantic salmon heart. Matching fields of consecutive sections from samples at 
various stages of HSMI disease development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, f). 
The scale bar in all figures is 500μm. a) Group 2, with no apparent lesions. b) PRV (red) was localized in the RBCs 
only (inset). c) Group 3, showing moderate epicarditis (star) and few inflammatory infiltrates in the compact layer 
(arrowheads) and spongy layer of the myocardium (arrows). d) Nodules of PRV positive cardiomyocytes (red) are 
localized in the compact layer (arrowheads) and in the spongy layer (arrows) of the myocardium, particularly 
around blood vessel and associated with inflammatory infiltrates, although several cardiomyocytes also show no 
nearby inflammation. e) Group 4, showing severe epicarditis and widespread endocarditis, involving virtually all 
the compact layer (arrowheads) and extensive areas of the spongy layer (arrows) of the myocardium. f) A large 
number PRV positive cardiomyocytes (red) were observed virtually across all the compact layer of the myocardium 
(arrowheads), although several of PRV positive cardiomyocytes were also observed in the spongy layer, often 
associated with inflammatory infiltrates.  
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Fig. 4. Histopathology and ISH in Atlantic salmon heart. Matching fields of consecutive sections from samples at 
various stages of HSMI disease development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, f). 
The scale bar in all figures is 100μm. a) Group 3, showing nodule of inflammatory infiltrate (circle) in the compact 
layer of the myocardium, in proximity to two small blood vessels (arrowheads). b) PRV (red) was localized in 
cardiomyocytes involved by the inflammatory infiltrate (circle). c) Group 3, showing inflammatory infiltrates in the 
spongy layer of the myocardium (arrowheads). d) PRV positive cardiomyocytes (red) were involved by the 
inflammatory infiltrates, although several cardiomyocytes also showed no nearby inflammation (arrowheads). e) 
Group 4, showing a severe, chronic endocarditis and myocardial degeneration (arrowheads) across the whole 
compact layer of the myocardium. f) A large number PRV positive cardiomyocytes (red) were observed virtually 
across the whole compact layer of the myocardium. Several cardiomyocytes are replete with PRV (arrows). 
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Fig. 5. Histopathology and ISH in Atlantic salmon liver. Matching fields of consecutive sections from samples at 
various stages of HSMI disease development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, f). 
The scale bar in all figures is 100μm. a) Group 2, with no apparent lesions. b) PRV (red) was localized in the RBCs 
(arrows) only. c) Group 3, with no apparent lesions. d) PRV (red) was present in the RBCs (arrows), but was mostly 
localized in the hepatocytes’ cytoplasm (arrowheads). e) Group 4, showing extensive areas of hepatic necrosis 
(stars), mostly presenting the typical “heart failure” pattern of distribution. f) PRV (red) was still localized mostly in 
the hepatocytes’ cytoplasm (arrowheads). 
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Fig. 6. Histopathology and ISH in Atlantic salmon posterior kidney. Matching fields of consecutive sections from 
samples at various stages of HSMI disease development are stained with H&E (a, c, e) and ISH for PRV-1 L1 
segment (b, d, f). The scale bar in all figures is 100μm. a) Group 2, with no apparent lesions. b) PRV (red) was 
localized in the RBCs (arrows), but also a few macrophages (arrowheads). c) Group 3, showing mild interstitial 
hyperplasia. d) PRV (red) was present in the RBCs (arrow), but was mostly localized in the peritubular (renal portal) 
macrophages (arrowheads). e) Group 4, showing mild interstitial hyperplasia. f) PRV (red) was still localized mostly 
in the macrophages (arrowheads).  
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Fig. 7. Histopathology and ISH in Atlantic salmon spleen. Matching fields of consecutive sections from samples at 
various stages of HSMI disease development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, f). 
The scale bar in all figures is 500μm. a) Group 2, with no apparent lesions. b) PRV (red) was localized in the RBCs 
(arrowheads), but also in some macrophages (arrowheads) (inset). c) Group 3, with no apparent lesions. d) A large 
number of PRV positive RBCs (red) were collected in the red pulp (arrows), along with PRV positive macrophages 
nearby the sinusoids. e) Group 4, showing mild congestion and moderate necrosis of the ellipsoids (arrows). f) A 
large number of PRV positive RBCs (red) were collected in the red pulp (arrows), although a larger number of 
damaged, PRV positive macrophages were observed in the ellipsoids (arrowheads).  
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Chinook salmon 
As the Chinook salmon used in our study were all from the DFO audit program, sampling only moribund 
and recently dead fish, we did not have true disease negative “controls” to use in our study. Hence, we 
restrict our analysis and description of histopathology and ISH to fish with molecular detection of PRV, 
which were further divided into groups depending upon whether they were classified as “VDD+” and 
whether they were diagnosed with jaundice/anemia (in which case they were all VDD+).  
Blood: PRV was detected in the RBCs from all fish with molecular detection of PRV. The marking was 
characterized by several dots of various sizes inside the cytoplasm of the cells (Fig. 2b). At times, the dots 
were so numerous as to basically fill the entire cytoplasm of the RBCs. The marking in the RBCs was 
particularly evident in fish that were not classified as “VDD”. 
Heart: No lesions in the heart were observed in fish that were not classified as “VDD+” (Fig. 8a), and in 
this fish PRV marking was restricted to the RBCs of the blood circulating inside the organ (Fig.8b). One 
fish (1/5) classifying as “VDD+” but not diagnosed with jaundice/anemia had mild endocarditis, localized 
exclusively in the spongy layer of the myocardium (Fig. 8c and 9a). In fish with “VDD+” alone, PRV was 
localized within some cardiomyocytes in the cytoplasm, mostly restricted to the spongy layer of the 
myocardium and often widespread in the tissue; a portion of these PRV-infected cardiomyocytes were 
associated with small nodules of inflammation (Fig. 8d and 9b). For fish diagnosed with jaundice/anemia, 
moderate or severe endocarditis in the spongy layer of the myocardium was identified in three out of 
nine fish, with sporadic inflammatory foci identified also in the compact layer. Overall, the inflammation 
was morphologically characterized by an infiltration of lymphocytes and macrophages, and was 
associated with focal areas of myocardial degeneration (Fig. 8e, 9c and 9e). In fish with jaundice/anemia, 
PRV was localized in the cardiomyocytes concentrated around regions with endocarditis in the spongy 
myocardium. Concurrently, a few cardiomyocytes of the compact layer also showed some dots of 
marking, and were usually associated with small aggregates of leucocytes (Fig. 8f, 9d and 9f).  
The localization of both heart lesions and PRV marking reported in the samples affected by 
jaundice/anemia was remarkably different from that observed in Atlantic salmon affected by HSMI, as 
shown in Fig. S3.  
Liver: One of three fish with molecular PRV detection but not classified as “VDD+” presented with 
severe hepatitis; this fish also had a confirmed case of rickettsiosis; the other two fish had no liver 
lesions (Fig. 10a). PRV was observed only in the RBCs in these fish (Fig. 10b). For fish classified only as 
“VDD+”, most (3/5) presented with widespread nodules and/or areas of moderate to severe necrosis, 
alongside broad areas of vacuolar degeneration (Fig. 10c). The same type of lesions (but often even 
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more extensive) were also observed in fish diagnosed with jaundice/anemia (5/9), at times associated 
with inflammatory infiltrate (1/9) (Fig.10e). Two fish (* in Table 3) had no necrotic areas, but virtually all 
hepatocytes had varying degrees of vacuolar degeneration, characterized by a foamy cytoplasm. In fish 
classified as “VDD+”, areas including cells affected by vacuolar degeneration and necrosis contained 
strongly positive PRV marking (Fig. 10d), however in fish diagnosed with jaundice/anemia, extended 
necrotic areas were positive for PRV, but to a lesser degree (Fig. 10f). Overall, in Chinook salmon positive 
for PRV and showing molecular signs of viral disease (VDD+), there was no distribution pattern of 
necrosis (as opposed to what observed in Atlantic salmon), and the type of lesions was more likely to be 
attributable to hypoxia due to anemia. 
Kidney: Most fish in our study had varying degrees of interstitial hyperplasia (3/3, 4/5 and 8/9, 
respectively); mostly mild and moderate in fish not diagnosed with jaundice/anemia (Fig. 11a), but 
occasionally severe in fish diagnosed with jaundice/anemia. In fish not classified as “VDD+”, PRV was 
localized in few RBCs as well as in some macrophages and melanomacrophages (Fig. 11b). Fish that were 
classified as “VDD+” or “VDD+ with jaundice/anemia” were also characterized by the presence of mild to 
severe necrosis of the renal tubules (3/5 and 3/9, respectively) (Fig. 11c and 11e), where there was also 
a substantial increase in the number of PRV positive macrophages. PRV marking were also found in the 
cytoplasm of damaged epithelial cells of the tubules and in the necrotic material inside the degenerate 
tubules (Fig. 11d). The occurrence of necrotic tubules and associated macrophage proliferation was 
intensified in fish diagnosed with jaundice/anemia (Fig. 11f). Four of nine fish diagnosed with 
jaundice/anemia also presented with mild to severe nephritis.  
Spleen: No lesions were observed in the spleen of fish with molecular detection of PRV that were not 
classified as “VDD+” (Fig. 12a), for which PRV was present in only a few RBCs and reticular macrophages 
of the ellipsoids and around the sinuses (Fig. 12b). However, most of the fish classified as “VDD+” or 
“VDD+ with jaundice/anemia” presented with mild to moderate spleen congestion (3/5 and 4/9, 
respectively), mild to severe white pulp hyperplasia (2/5 and 4/9, respectively) and, in some cases, mild 
to severe necrosis of the ellipsoids (3/5 and 4/9, respectively) (Fig. 12c and 12e). As well, one fish 
diagnosed with jaundice/anemia showed signs of moderate hemosiderosis. The number of marked RBCs 
was considerably higher in fish classified as “VDD+”, compared to those with no “VDD+” classification; 
these PRV-infected cells localized primarily in the sinusoids, which became engorged, distended and 
easily identifiable. An increase in positively marked macrophages around the sinusoids was also 
observed (Fig. 12d). In fish diagnosed with jaundice/anemia, the amount of PRV-infected RBCs and 
macrophages further increased to eventually occupy most of the organ, making it quite difficult to 
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recognize the localization of the engulfed sinusoids within the red pulp, and reducing the white pulp to 
few, scattered nodules (Fig. 12f). 
Intestine: No lesions in the intestine were observed in any of the Chinook salmon in our study (Fig. S4a, 
S4c and S4e), although positively marked RBCs were observed in all fish (Fig. S4b). Several enterocytes 
were also marked in fish classified as “VDD+” (Fig. S4d), but decreased in those diagnosed with 
jaundice/anemia (Fig. S4f). 
 
A biplot PCA based on lesion scores from Table 3 depicts strong differential clustering between Atlantic 
and Chinook salmon along PC1 and PC2, respectively (Fig. 13). HSMI developmental stages in Atlantic 
salmon are well differentiated along PC1 (36.11% variation), while jaundice/anemia in Chinook salmon is 
highly loaded on PC2 (23.74% variation), although with more overlap between stages of disease 
development. Heart epicarditis and endocarditis, as well as myositis (muscle_itis), were the most 
differentiating lesions along PC1. Kidney interstitial hyperplasia was most strongly associated with PC2 
(and jaundice/anemia), with contributions from splenic white pulpitis (spleen_wpu itis) and nephritis 
(kidney_itis). Liver necrosis was intermediate between PC1 and PC2, with higher levels associated with 
stronger disease development; however, this was a general category and the pattern of necrosis was 
notably different between the two species, as mentioned above. Necrosis of the splenic ellipsoids 
(spleen_ell nec) was also intermediate, increasing with disease development for both Atlantic and 
Chinook salmon. Barnard exact tests identified these same lesions as most differentiating between 
Atlantic and Chinook salmon within each stage of disease development (Table S2). 
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Fig. 8. Histopathology and ISH in Chinook salmon heart. Matching fields of consecutive sections from samples at 
various stages of jaundice/anemia development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, 
f). The scale bar in all figures is 500μm. a) Group 1, with no apparent lesions. b) PRV (red) was localized in the RBCs 
only (inset). c) Group 2, showing small nodules of endocarditis (arrows) involving the spongy layer of the 
myocardium (hash). d) PRV positive cardiomyocytes (red) are localized in the spongy layer (arrows), in association 
with small inflammatory infiltrates. e) Group 3, showing severe endocarditis in the spongy layer of the myocardium 
(hash). f) Several PRV positive cardiomyocytes (red) were observed in the spongy layer of the myocardium 
(arrows), associated with severe endocarditis.  
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Fig. 9. Histopathology and ISH in Chinook salmon heart. Matching fields of consecutive sections from samples at 
various stages of jaundice/anemia development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, 
f). The scale bar in all figures is 100μm. a) Group 2, showing small aggregates of leucocytes (arrows) surrounding 
cardiomyocytes in the spongy layer of the myocardium. b) PRV positive cardiomyocytes (arrows) are localized 
nearby the small nodules of endocarditis. PRV positive RBCs are also present in the lumen of cardiac cavity 
(arrowhead). c) Group 3, showing a small, single nodule of inflammation (circle) in the compact layer of the 
myocardium. d) PRV (red) was localized in cardiomyocytes nearby the inflammatory infiltrate (arrows). A few PRV 
positive RBCs (arrowheads) were present inside blood vessels. e) Group 3, showing diffuse, severe endocarditis in 
the spongy layer of the myocardium. f) PRV positive cardiomyocytes (red) are localized in the spongy layer 
(arrows). A few PRV positive RBCs are also present in the lumen of cardiac cavity (arrowhead).  
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Fig. 10. Histopathology and ISH in Chinook salmon liver. Matching fields of consecutive sections from samples at 
various stages of jaundice/anemia development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, 
f). The scale bar in all figures is 100μm. a) Group 1, with no apparent lesions. b) PRV (red) was localized in the RBCs 
(arrows) only. c) Group 2, showing areas of vacuolar degeneration (arrows) and necrosis (arrowheads). d) PRV 
(red) was diffusely present in degenerated and necrotic hepatocytes. e) Group 3, showing diffuse hepatic necrosis 
and few inflammatory cells (arrowheads). f) PRV (red) was localized mostly in the cytoplasm of the few, viable 
hepatocytes (arrows). A few RBCs were also positive to PRV (arrowheads). 
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Fig. 11. Histopathology and ISH in Chinook salmon posterior kidney. Matching fields of consecutive sections from 
samples at various stages of jaundice/anemia development are stained with H&E (a, c, e) and ISH for PRV-1 L1 
segment (b, d, f). The scale bar in all figures is 100μm. a) Group 1, showing mild interstitial hyperplasia. b) PRV 
(red) was localized in the RBCs (arrows), but also a few macrophages (arrowheads). c) Group 2, showing interstitial 
hyperplasia and several necrotic renal tubules (stars). d) PRV (red) was mostly localized in the peritubular (renal 
portal) macrophages (arrowheads), but viral particles were also present in the material contained inside the 
necrotic tubules (arrows). e) Group 3, showing interstitial hyperplasia and several necrotic (stars) and damaged 
(hash) renal tubules. f) PRV (red) was localized mostly in the macrophages (arrowheads), as well as in the material 
contained inside the necrotic tubules (arrows).  
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Fig. 12. Histopathology and ISH in Chinook salmon spleen. Matching fields of consecutive sections from samples at 
various stages of jaundice/anemia development are stained with H&E (a, c, e) and ISH for PRV-1 L1 segment (b, d, 
f). The scale bar in all figures is 500μm. a) Group 1, with no apparent lesions. b) PRV (red) was localized in the RBCs 
(arrows), but also in some macrophages (arrowheads) (inset). c) Group 2, showing increased congestion and white 
pulp hyperplasia. d) A large number of PRV positive RBCs (red) were aggregated in the red pulp, highlighting the 
position of the sinusoids (arrows), along with PRV positive macrophages nearby the sinusoids. e) Group 3, showing 
blood congestion. f) PRV (red) was localized in virtually any RBCs and macrophages of the red pulp.  
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Fig. 13. Biplot for PCA of 35 samples (18 Atlantic and 17 Chinook) and 12 lesions (8 inflammatory and 4 necrotic; 
necrotic lesions: 'liver_nec', 'spleen_ell nec', 'kidney_osis' and 'kidney_nec"). The number displayed next to two 
points representing Atlantic salmon indicates the number of fish that have the exact same lesion scores (and 
therefore have the same PC scores and are plotted on top of each other). The bottom and left axes show sample 
scores for PC1 and PC2 scaled to unit sums-of-squares (colored points and squares) while the top and right axes 
show variable loadings scaled by the standard deviation of the principal components times the square root of the 
number of samples. 
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Immunohistochemistry with antibody to hemoglobin 
The immunohistochemistry carried out against hemoglobin subunit beta demonstrated positive marking 
in the RBCs of all samples, as expected. However, all samples belongings to the “PRV+/VDD+” group and 
the “jaundice/anemia” group (6 out of 6) tested for hemoglobin also showed positive marking in the 
material (renal casts) contained in the lumen of the necrotic renal tubules (where present), and some 
hemoglobin-positive material was found in a few apparently healthy epithelial cells of the renal tubules 
(Fig. 14a-d). This finding was totally absent in all fish belonging to the “PRV+ only” group (2 out of 2) and 
in the negative control samples. 
Positively marked hepatocytes were also observed in the samples belonging to the “PRV+/VDD+” and 
“jaundice/anemia” groups. In the “PRV+/VDD+” group, some hepatocyte presented with 
intracytoplasmic hemoglobin-positive vacuoles (Fig. 14e). In “jaundice/anemia” group, almost any 
hepatocyte presented with some degree of marking to hemoglobin, in particular cells identified by 
apoptotic nuclei and associated with a large, clear intracytoplasmic vacuole (Fig. 14f). 
 
PRV Phylogenetic Sequence analysis 
Phylogenetic analysis of the S1 segment including both the PRV-2 and PRV-3 strains shows that the 
divergence between sequence variants within the PRV-1 strain is low compared to the evolutionary 
distance between PRV-1, 2 and 3 (Fig. 15). Based on the S1 segment, all BC sequence variants fell within 
a single phylogenetic cluster within PRV-1, which also included sequences from Norway (Atlantic 
salmon), and Chile (Coho salmon). Although PRV-1 has previously been broken down into sub-strains 
PRV-1a and 1b, this distinction is not helpful considering that there are sequences which lie somewhere 
between the two sub-strains (e.g. JN991012.1, JN991007.1), and further sequencing of the PRV-1 
quasispecies will likely see these sub-strains break down. Within PRV-1, the single Norwegian reference 
sequence utilized was the most divergent, with BC strains generally grouping together (Fig. S5). From 
the available data, there is more variation within PRV-1 in Norway than in BC, where, despite infection in 
different species, there is little variation between samples. 
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Fig. 14. Histopathology and immunohistochemistry in Chinook salmon posterior kidney and liver. Matching fields 
of consecutive sections from kidney samples at various stages of jaundice/anemia development are stained with 
H&E (a, c) and IHC for hemoglobin (b, d). The scale bar in all figures is 100μm. Two liver samples stained with IHC 
for hemoglobin (e and f) from two different stages of jaundice/anemia development. Scale bar in all samples is 
100μm. a) Kidney of fish belonging to group 2, showing necrotic material (renal casts) in lumen of necrotic renal 
tubules (stars). b) Hemoglobin (brownish red) is observed in RBCs (arrowheads) and in the material contained in 
the necrotic renal tubules (arrows). c) Kidney of fish belonging to group 3, showing necrotic material (renal casts) 
in lumen of necrotic renal tubules (stars). d) Hemoglobin (brownish red) is observed in RBCs (arrowheads), in the 
material contained in the necrotic renal tubules (arrows) and as inclusions in the epithelial cell of some apparently 
healthy renal tubules (open arrowhead). e) Liver of fish belonging to group 2, showing widespread, 
intracytoplasmic hemoglobin-positive vacuoles (brownish red – arrows). f) Liver of fish belonging to group 3, 
showing diffuse hemoglobin marking (brownish red), and particularly concentrated in hepatocytes presenting with 
apoptotic nucleus and a large, clear, intracytoplasmatic vacuole (arrows).   
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The Bayesian inference of phylogeny of PRV sequences from Atlantic and Chinook salmon from this 
study did not show consistent differences among sequence variants for each segment (Fig. S5). For each 
sample, the sequence variation within segments was remarkably low when compared with the 
Norwegian sequence. Nucleotide sequence identities among PRV-1 sequences in BC were >99%, with 
minor variance among segments (minimum identity of 99.4; S1). Alternatively, when PRV-1 was 
compared with Strains PRV-2 and PRV-3, the nucleotide identities were 73.4% and 80.1%, respectively 
(Dhamotharan et al. 2018), whereas the minimum sequence identity within PRV-1 was >95.1% in the S1 
segment (Godoy et al. 2016). 
Although some trees depict a degree of differential clustering among salmon species (e.g. M1, M2), 
close inspection of the multiple sequence alignment (not shown) did not reveal any SNPs consistently 
different between species if the reference genome from Norway was included in the analysis (see Fig. S5 
for all trees). Perhaps the most distant clustering between sequences derived from Atlantic and Chinook 
salmon occurred for the M1 segment, which was supported by a posterior probability of 0.999. 
For Chinook salmon, we sequenced PRV from the west and east coasts of Vancouver Island, and found 
that for all but segment S1, the west coast samples (labeled P2) clustered tightly together (Fig. S5). 
However, all four west-coast samples were from the same company, with farms in close proximity to 
one another. In contrast, the Atlantic salmon were from farms on the east coast of Vancouver Island 
(A3.2 and A3.3) and the central coast of BC (A3.5), there was no obvious geographic pattern in sequence 
clustering, nor a pattern associated with individual companies (data not shown). We also did not 
observe particularly close clustering of sequences from fish sampled from the same farm three months 
apart (samples G460 and G383), nor from those taken from different year-classes within the same farm 
(G808 and G609). However, PRV-1 from a semi-close-contained Chinook salmon farm (G444) was 
generally the most divergent from other Pacific salmon sequences. 
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Fig. 15. Bayesian inference of phylogeny of the PRV S1 segment comparing sequence variants from Atlantic and 
Chinook salmon from farms containing fish diagnosed with HSMI or jaundice/anemia, respectively as well as 
representatives of all PRV strains identified worldwide. GU994017.1 is the first PRV sequence identified in Palacios 
et al. (2010). KY429949.1 is the PRV-1 sequence for the virus demonstrating a cause and effect relationship with 
HSMI (Wessel et al. 2017). The Bayesian support values (posterior probability) are labelled and the scale bar 
represents number of nucleotide substitutions per site. Largemouth bass reovirus (LMRV) was included as an 
outgroup. PRV genome sequences were deposited to GenBank under accession numbers MH093900 - MH094029. 
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Discussion 
This is the first study to specifically localize PRV across multiple tissues during disease development in 
salmon. We demonstrate an intimate relationship between viral localization and development of 
histological lesions that supports an etiological role for the virus in the development of both HSMI in 
Atlantic salmon and jaundice/anemia in Chinook salmon. It is already established that Strain PRV-1 
causes HSMI in Atlantic salmon (Wessel et al. 2017), and that Strain PRV-2 causes EIBS in Coho, a 
jaundice/anemia-related disease in Japanese Coho salmon (Takano et al. 2016). Moreover, strains of 
PRV have been associated with other diseases. For example, PRV-1 has been associated with jaundice 
syndrome in farmed Chinook (Miller et al. 2017) and Strain PRV-3 with HSMI-like disease and anemia in 
Rainbow trout in Norway (Olsen et al. 2015) and Coho salmon in Chile (Godoy et al. 2016). Therefore, all 
the three recognized strains of PRV have now been affiliated with a jaundice-related disease in three 
species of Pacific salmon, and weight of evidence worldwide, and our findings in BC, suggests that PRV-
1, the only PRV strain detected in BC salmon, likely causes both diseases, HSMI and jaundice/anemia, in 
Atlantic and Pacific salmon respectively. 
Full viral genome sequencing of PRV in Chinook salmon diagnosed with jaundice/anemia or classified as 
PRV+/VDD+, sampled from seven farm audits collected over three years, and in Atlantic salmon 
diagnosed with HSMI, sampled over three years from six farm audits distributed across the BC industry, 
validated that only closely related sequence variants within PRV-1 occur on BC farms. The sequence 
variants of PRV-1 from BC share high sequence identity to sequences in Norway (maximum 99.7% 
identity [JN991006.1]) and Chile (maximum 99.7% identity [KU131591.1 from Coho]) for S1, which is 
within the range of variation observed in BC. Over the entire viral genome maximum sequence identity 
between BC variants of PRV-1 and the first PRV-1 sequence described by Palacios et al. (2010) was not 
as high, and varied among segments from 96.6 (S1) to 99.2 (M1).  S1 and M2 are the two segments 
showing strongest divergence between this Norwegian sequence and BC PRV-1 variants (96.6 and 96.8 
percent respectively). In Mammalian orthoreovirus (MRV) these segments code for proteins that confer 
virulence in mice (Weiner et al. 1977; Rubin and Fields 1980), with S1 coding for the cell-attachment 
protein, which is important for neurovirulence and tissue tropism (Weiner et al 1977). If these proteins 
have similar functions in Piscine orthoreovirus, it is possible that the minor differences observed 
between the Palacios Norwegian and BC sequence variants of PRV-1 could result in shifts in 
virulence. This is an area that will be examined in future challenge studies. 
While there were no consistent differences in PRV-1 sequences between Atlantic salmon with HSMI and 
Chinook salmon with jaundice/anemia, sequences from Atlantic salmon clustered separately from 
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Chinook salmon for the L1, M1, and M2 segments; however, there were no single-nucleotide or amino-
acid substitutions that were consistently differential between salmon species (data not shown). Hence, 
the low sequence divergence within PRV-1 is consistent with the virus cross-infecting Atlantic and 
Chinook salmon, and suggests that the virus can transmit diseases between salmon species.  
The molecular viral disease development panel, or VDD,  was developed in the Miller et al. (2017) study 
from meta-analysis of multi-cohort microarray data from viral disease challenge studies for five diseases 
caused by RNA viruses (infectious hematopoietic necrosis [IHN], infectious pancreatic necrosis [IPN], 
infectious salmon anemia [ISA], cardiomyopathy syndrome [CMS] and heart and skeletal muscle 
inflammation [HSMI]), and validated using RNA samples from independent challenge (IHNV across 
multiple species) and field (HSMI in Atlantic salmon and jaundice/anemia in Chinook salmon) samples. In 
addition to differentiating carrier and disease states for viruses, the VDD panel could also differentiate 
bacterial and viral disease states. It was shown that a robust set of eleven VDD biomarkers was all that 
was required; these included SRK2, DEXH, RSAD, UBL1, IFIT5, NFX, HERC6, VHSVIP4, IF44A, CD9, and MX.  
The application of the VDD panel was particularly useful in understanding the disease development 
process, and identifying fish at an early stage of disease progression, before clinical (and sometimes 
morphological) evidence of disease is recognized. In applying this tool across both Atlantic and Pacific 
salmon, we demonstrated that almost all fish diagnosed specifically with PRV-associated disease (HSMI 
or jaundice/anemia) showed a strong host VDD response. Exceptions were two Atlantic salmon with low 
PRV load that we surmise may have been in a recovery stage whereby lesions persist after the virus is all 
but cleared, as demonstrated in Norwegian studies (Finstad et al. 2012). Fish specifically diagnosed with 
disease account for only 17% of Atlantic salmon and 41% of Chinook salmon with PRV loads > 104 copies 
per µg nucleic acids classifying as VDD+, suggesting that many more fish may have been in a pre-clinical 
disease state. However, in both species, there are also fish (33% for Atlantic, 19% for Chinook salmon) 
that contain PRV loads > 104 copies per µg nucleic acids that do not classify as VDD+. Our research also 
shows that in these fish, the virus was not observed outside of the RBCs, the primary infective cells for 
PRV. These data support the hypothesis put forward by Finstad et al. (2014) and Wessel et al. (2015) 
that PRV is highly tolerated by the salmon host (Atlantic salmon) when replicating exclusively in RBCs, 
and that the host elicits no strong immune reaction or pathological response as long as the virus remains 
in RBCs (classified in our study as PRV+ only). This explains what has been considered an anomalous 
finding that fish with high loads of the virus may or may not show any indication of disease, which led 
some scientists to speculate that PRV is not a primary cause of disease (Garver et al. 2016), later refuted 
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in the study by Wessel et al. (2017) demonstrating a cause and effect relationship between PRV-1 and 
HSMI.  
Through application of the molecular VDD tool, and differentiation of fish in a PRV+ carrier state from 
those at early stages of disease development, we also learn that this anomaly is not as strong in Chinook 
salmon as it is in Atlantic salmon. All Chinook salmon in our study with mixed tissue PRV >105 copies per 
µg nucleic acids classified as VDD+ and showed evidence of RBC rupture, leading to release of virus and 
high levels of hemoglobin into the tissues. These data are consistent with an upper limit of load 
tolerance to infection of RBCs in Chinook salmon that is not observed in Atlantic salmon which that may 
result in a higher susceptibility of Chinook salmon to disease development. Ideally, an exact tolerance 
threshold value needs to be determined experimentally, specifically monitoring loads in RBCs, but the 
use of regulatory audit fish, that were moribund or dead upon sampling, precluded this possibility.  
Our ISH data indicate that RBC lysis and release of virus in Chinook salmon results in the elicitation of an 
immediate strong ‘viral disease’ host response (VDD). Additionally, we observed hemosiderin 
appearance in the spleen of some fish (evidence of metabolized hemoglobin from ruptured RBCs), and 
massive erythrophagocytosis of damaged/ruptured RBCs (containing PRV) and possibly free virus in 
spleen and kidney. Immunohistochemistry analysis for hemoglobin also confirmed the presence of high 
level of hemoglobin in the liver (particularly in damaged/apoptotic hepatocytes) and kidney (in the renal 
casts resulting from renal tubules necrosis) of fish diagnosed with jaundice/anemia or even just 
PRV+/VDD+. High levels of hemoglobin, bilirubin and heme byproduct are known to be toxic for the liver 
cells (Sakai et al. 1994) as well as for the epithelial cells of the kidney tubules (Tracz et al. 2007; Deuel et 
al. 2016). These are similar disease characteristics to comparable PRV-related diseases in Pacific salmon 
in Chile, Japan and Norway (Sakai et al. 1994; Smith et al. 2006; Olsen et al. 2015; Godoy et al. 2016; 
Takano et al. 2016). Moreover, mild to severe myocarditis primarily involving the spongy layer of the 
myocardium (as opposed to the whole heart, including mostly the epicardium and compact layer of the 
myocardium, in HSMI) occurs transiently in Chinook salmon. This pattern of inflammation has also been 
observed in PRV-associated diseases in Coho salmon and Rainbow trout (Hayakawa et al. 1989; Olsen et 
al. 2015; Godoy et al. 2016).  
Interestingly, many of the Chinook salmon classified as PRV+/VDD+, but not with jaundice/anemia, 
pathologically showed advanced states of disease, suggesting that clinical signs (i.e. jaundice and 
anemia), which were principally used to classify fish in our study, may occur quite late in the disease 
process, potentially resulting in low diagnostic sensitivity on farms. Moreover, at the peak of the clinical 
manifestation of the disease, the virus is not always prevalent in the heart, and myocarditis lesions are 
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not always present, suggesting a temporary occurrence of these lesions. By contrast, extensive areas of 
hepatonecrosis and kidney tubule necrosis are present in regions with high abundance of virus. Whether 
these degenerative/necrotic lesions are the result of viral infection specifically in the cells that become 
necrotic, or through the toxic levels of heme being collected, processed and accumulated by these 
tissues, is not clear, but in either case, these changes are clearly associated with PRV-1 virus-associated 
hemolysis.  
ISH analysis of the HSMI disease development process in Atlantic salmon, known to be caused by PRV-1 
infection, showed a strong association of the virus within regions and cells showing tissue damage. In 
the “developing” stage, the virus begins to move outside of RBCs and infect cardiomyocytes, mostly in 
the compact layer of the myocardium, but also, to a lesser extent, in the spongy layer, as was also 
indicated through immunohistochemistry by Wessel et al. (2017). In this early stage of disease, several 
cardiomyocytes become infected. The cardiomyocytes damaged by the intracellular activity of the virus 
induce the inflammatory reaction of the host, identified as foci of inflammation characterized by the 
presence of lymphocytes and macrophages. When the fish were diagnosed with HSMI, high quantity of 
the virus, and associated inflammatory lesions, spread throughout the heart, resulting in panmyocarditis 
by involving both compact and spongy layers of the myocardium, and sometimes even the atrium.  
While our study did not specifically investigate ISH in skeletal muscle lesions (as we had difficulty 
breaking up muscle tissue sufficiently to allow our RNA probe to enter without causing the tissue to 
become over-digested or detach from the slide), we have described the temporal patterns of 
inflammatory lesions in skeletal muscle that track those in the heart (Di Cicco et al. 2017), and include 
these data herein. However, in Atlantic salmon, we investigated for the first time the viral localization in 
tissues other than the heart. Viral distribution in the spleen was similar to that in Chinook salmon in the 
early stages of disease, also showing erythrophagocytosis, but it didn’t reach the massive engulfment of 
damaged RBCs during the peak of the disease as demonstrated in Chinook salmon. Moreover, unlike in 
Chinook salmon, there was no evidence of necrotic lesions in liver (other than those described as “heart 
failure” pattern of necrosis) or kidney in most fish despite a moderate prevalence of the virus in 
hepatocytes and renal macrophages 
One common finding between HSMI and jaundice/anemia was the localization of PRV particles in the 
intestine (i.e. enterocytes), particularly during the early stages of disease development, when a high 
amount of virus is free in the blood. This finding suggests and confirms that the intestine can act not 
only as an entry point for the virus, but also as a possible route for virus dissemination in the 
environment, as previously indicated by Hauge et al. (2016). 
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Our study was able to illustrate that the key difference in the PRV-associated disease manifestation in 
Atlantic and Pacific salmon probably lies in the difference between the ability of the species to tolerate 
high loads of the virus in RBCs. In HSMI, there is no evidence of RBC lysis (also, no anemia clinically 
reported), but rather PRV appears to leak from RBCs upon reaching a high viral load. We hypothesize 
that at that stage, the virus moves into the plasma and infects other cell types, with particular 
predilection for cardiomyocytes and (to a lesser extent) myocytes of the skeletal muscle. Not being able 
to support viral replication, these cells undergo structural changes that expose the virus itself or 
antigenic cellular components that eventually trigger the inflammatory reaction within these tissues. 
This type of reaction is cell mediated (CD8+ and macrophages) as demonstrated by Mikalsen et al. 
(2012), characterizing a typical Type IV hypersensitivity reaction. If inflammation becomes severe, it can 
result in heart failure and death.  
By contrast, there is consistent evidence of RBC rupture (e.g. anemia, hemosiderin, enhanced 
macrophages-erythrophagocytosis, hemorrhaging, excess of free hemoglobin, excess of free bilirubin 
and jaundice) in PRV-associated diseases in Pacific salmon around the world (Sakai et al. 1994; Olsen et 
al. 2015; Godoy et al 2016; Takano et al. 2016), suggesting that PRV is released “en masse” during RBC 
lysis. This would also result in large quantities of hemoglobin being released into the tissues. 
Hemoglobin is catabolized and removed by hepatocytes, which can be overwhelmed by toxic levels of 
the breakdown product heme, and the yellow compound, bilirubin, byproduct of heme catabolism. 
Exposure to toxic levels of these byproducts can result in necrosis of the hepatocytes (Sakai et al. 1994), 
degeneration and necrosis of the epithelial cells of kidney tubules (Tracz et al. 2007; Deuel et al. 2016), 
leading to a yellow appearance of the internal organs (especially the liver) and in extreme cases the 
epithelial cells on the body of the fish. These lesions can also potentially lead to liver and kidney failure, 
and eventually death. Anemia, reported in all Pacific salmon species affected by strains of PRV (Olsen et 
al. 2015; Godoy et al 2016; Takano et al. 2016), also results from a massive reduction in RBCs that could 
lead to a reduced oxygen uptake capacity and hence a substantially higher short-term morality rate. 
Hence, the occurrence of transitory lesions in the heart seems to be characterized by a pathogenic 
mechanism different to the one affecting liver and kidney. The type of lesions reported for such organs 
also support this hypothesis, being inflammatory processes primarily involved in the heart (just like 
HSMI, despite a different viral localization/tropism in Chinook), and degenerative/necrotic processes in 
liver and kidney.  
Given that Piscine orthoreovirus Strain PRV-1 causes HSMI in farmed Atlantic salmon, and likely causes 
jaundice/anemia in farmed Chinook salmon, the absence of consistent sequence variation within  PRV-1 
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in diseased Atlantic and Chinook salmon implies a risk of transmission of the virus from farmed salmon 
to wild Pacific salmon. As Atlantic salmon accounts for 97% of the total biomass of farmed salmon in BC, 
answering the question of whether the virus causing HSMI in Atlantic salmon causes disease in Pacific 
salmon is critical when assessing risk. PRV-1 occurred in 65-75% of farm audit samples of Atlantic and 
Chinook salmon, with approximately 25% of the salmon having high viral loads. In farms where HSMI 
disease ensues, BC Atlantic salmon show a morbidity rate (i.e. presence of histological lesions) of >80%, 
similarly to that reported in Norway (Kongtorp et al. 2004a; Kongtorp et al. 2006), and retain high loads 
of the virus and evidence of inflammatory lesions for a prolonged period of time (in the study reported 
by Di Cicco et al. (2017), over 11 months). Hence, the environmental footprint and potential for viral 
transmission to wild salmon from disease-impacted farms is likely high. While neither disease has yet 
been identified in wild fish to date, given the high sensitivity of the molecular viral disease development 
tool to early developing disease states, and of ISH to localize the virus across tissues, we can now apply 
these approaches to empirically determine whether any evidence exists that PRV-associated diseases 
may be occurring in migratory salmon in BC.  
HSMI is one of the most common infectious diseases of Norwegian farmed salmon (Garseth et al. 2017). 
Moreover, disease modeling has identified that fish farming intensity in a region is a major risk factor for 
HSMI outbreaks (Kristoffersen et al. 2013; Morton et al. 2017), suggesting that water-borne 
transmission may be an important factor in the spread of disease (Hjeltnes et al. 2016). These data also 
suggest that farming intensity could enhance exposure of migrating smolts to PRV (Garseth et al. 2017). 
Escaped farmed salmon, which are most often infected with PRV, could also be a transmission vector for 
freshwater infections in wild fish if they enter rivers (Madhun et al. 2015; Hjeltnes et al. 2016, 2017). 
Importantly, there have been recent reports of HSMI outbreaks occurring in freshwater hatcheries in 
Norway, which represents a shift in what was considered until recently a disease restricted to sea net 
pens (Hjeltnes et al. 2016, 2017). There is some indication as well, that PRV infection in freshwater may 
be associated with earlier, and more significant HSMI outbreaks in sea net pens, and as a result, some 
farmers are attempting to produce PRV-free smolts (E. Rimstad, personal communication, 2017; 
Hjeltnes et al. 2017). 
Prevalence of PRV is low (<3%) in wild migrating BC Chinook and Sockeye salmon smolts that have not 
been exposed to salmon farms (Siah et al. 2015; Morton et al. 2017; Purcell et al. 2018; Tucker et al. 
2018; Miller, unpublished data). Higher prevalence is observed in fall, especially in Chinook salmon on 
the west coast of Vancouver Island that remain resident in the same bays and inlets occupied by salmon 
farms for prolonged periods of time (up to a year) (Miller, unpublished data). An epidemiological study is 
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currently underway to assess the role of salmon farms in the transmission of PRV to wild stocks, based 
both on patterns of prevalence distributions and full genome sequencing of the virus across farmed and 
wild populations over multiple years and geographic locations.  
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Tables 
Table 1. Atlantic salmon collected during an outbreak of HSMI in a longitudinal farm study.   
Group 
Fish 
# 
Date 
Fork 
Length 
(mm) 
Total 
Fish 
Mass      
(g) 
L-M-D Epi End 
Heart 
Score 
SkM Pathologist 
PRV                         
(cn/µg) 
Kudoa 
thyrsites                         
(cn/µg) 
Desmozoon 
lepeoptherii                       
(cn/µg) 
1                 
(CTRL) 
B5586 28/08/2013 340 440 L 0 0 0 0 ED     1.2E+05 
B5589 28/08/2013 285 260 L 0 0 0 0 ED   5.9E+07 1.2E+06 
B5398 28/08/2013 350 490 L 0 0 0 0 ED   4.8E+06 6.4E+06 
B5399 28/08/2013 325 365 L 0 0 0 0 ED     1.2E+05 
B5385 28/08/2013 350 465 L 0 0 0 0 ED     1.7E+03 
B5400 28/08/2013 350 550 L 0 0 0 0 ED     4.8E+05 
2    
(PRV+/HSMI-) 
B5389 28/08/2013 350 470 L 0 0 0 0 ED 8.3E+04   3.5E+04 
B5760 11/09/2013 365 590 L 0 0 0 0 ED 7.7E+05   2.8E+03 
B5903* 09/10/2013 385 695 L 0 0 0 0 ED 5.5E+04   1.1E+04 
B5940 09/10/2013 385 695 L 0 0 0 0 ED 3.9E+05 9.3E+04 1.4E+06 
B7274 23/10/2013 350 580 L 0 0 0 0 ED 2.9E+05   1.6E+06 
B7283 23/10/2013 300 330 L 0 0 0 0 ED 4.2E+05 3.4E+05 2.9E+05 
3    
(Developing) 
B5392 28/08/2013 350 510 L 2 1 3 0 ED 1.1E+03 2.8E+07 1.3E+05 
B5597 28/08/2013 260 230 D 1 0.5 1.5 0 ED 1.9E+04 1.1E+03 1.1E+04 
B5910* 09/10/2013 400 710 L 1 0.5 1.5 0 ED 2.3E+05   1.9E+06 
B5933* 09/10/2013 350 465 L 2 1 3 2 ED 1.1E+05 5.9E+05 4.3E+06 
B5937 09/10/2013 390 675 L 2 1 3 1 ED 1.8E+05 3.3E+05 3.2E+07 
B7273 23/10/2013 360 655 L 2 1 3 0 ED 3.7E+05 7.0E+02 1.6E+07 
4                  
(HSMI) 
B5690 11/09/2013 323 350 D 3 3 6 3 ED/HWF 4.6E+05 2.5E+06 2.5E+04 
B5688 11/09/2013 339 430 D 2 2 4 2 ED/HWF 6.3E+04   2.3E+05 
B7293 23/10/2013 425 985 D 3 3 6 2 ED 5.3E+03   8.0E+04 
B7483 05/11/2013 450 1200 D 3 3 6 3 ED/HWF 3.1E+04   4.5E+06 
B7474 05/11/2013 405 775 M 3 3 6 3 ED/HWF 1.4E+04   7.1E+04 
B7473 05/11/2013 375 745 M 3 3 6 2 ED/HWF 3.7E+04 4.3E+05 4.7E+05 
 
Note: Under the “L-M-D” column, “L” was live-, “M” was moribund-, and “D” was dead-sampled. HSMI scoring system includes inflammatory lesions in the epicardium (Epi), endocardium (End) and skeletal muscle (SkM). Also included are the infectious 
agents detected in the heart of each fish (“cn/µg”=“copy number per
 
µg of nucleic acids”). Samples marked with “*” indicated fish tested for infectious agents by pooled tissues (heart, liver, kidney, brain and gills).  
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Table 2. Distribution of Chinook salmon from the DFO audit program used to study PRV-related jaundice/anemia disease progression.   
                
Viruses                                                                                                       
(cn/µg)       
  
Bacteria
(cn/µg) 
  
Parasites                    
(cn/µg) 
  
  
Group Fish 
# 
Farm 
code 
Yea
r Quarter 
VDD 
PCA 
Viral 
State   PRV ENV   P. sal R. sal A. sal V. ang   L. sal D. lep P. pse   Diagnosis 
1           
(PRV+) 
G572 P.3-103 2013 3 2.902     7.4E+04       1.1E+02   3.8E+02     1.1E+02 4.4E+04   nephrocalcinosis 
G939 P.3-166 2013 4 4.820     1.9E+04           1.7E+02   1.5E+02 5.5E+02 3.8E+05   branchitis 
G869 P.2-99 2013 3 4.263     7.9E+03     6.7E+07         3.4E+04 9.9E+05 1.0E+03   rickettsiosis 
2    
(PRV+/VDD+) 
G459 P.2-3 2013 1 -13.308 VDD   1.0E+06                 4.4E+02 3.6E+02   BKD 
G363 P.2-3 2013 1 -18.825 VDD   5.2E+05       2.2E+04       1.0E+06 2.2E+02     IHN-like 
G772 P.2-99 2013 3 -13.475 VDD   2.2E+05 1.4E+03             6.3E+02 4.7E+04 5.8E+03   rickettsiosis 
G722 P.3-8 2011 4 -12.240 VDD   2.5E+04 1.4E+03         6.8E+05       8.9E+05   vibriosis 
G460 P.2-3 2013 1 -10.928 VDD   1.1E+06                 1.6E+06     anemia 
3   
(PRV+/VDD+    
jaundice/     
anemia) 
G364 P.2-3 2013 1 -11.256 VDD   5.1E+05               2.8E+02 3.9E+02 5.4E+02   jaundice/anemia 
G579 P.2-1 2011 2 -9.508 VDD   1.2E+07 3.5E+05             2.9E+06       jaundice 
G578 P.2-1 2011 2 -15.870 VDD   5.9E+06                       jaundice/anemia 
G481 P.2-1 2011 2 -13.101 VDD   1.9E+06               5.3E+04 2.5E+02     jaundice/anemia 
G417 P.3-120 2012 3 -15.644 VDD   8.5E+05 8.0E+04             9.2E+06 1.1E+02 9.3E+03   jaundice/anemia 
G172 P.2-3 2013 1 -10.282 VDD   2.5E+05               1.9E+03 2.0E+03 2.6E+02   jaundice/anemia 
G563 P.2-95 2013 2 -17.639 VDD   3.5E+05 3.9E+04     8.1E+01         2.0E+04     jaundice 
G287 P.2-95 2013 2 -14.137 VDD   2.6E+05 9.8E+03   1.0E+02 5.5E+02         2.5E+05 1.3E+03   jaundice 
G673 P.2-1 2011 2 -10.108 VDD   1.6E+05                       jaundice 
 
Note: Samples were divided up into three developmental stages, including a pre-disease state whereby fish contained high PRV loads but no evidence of a viral disease state (VDD) or histological lesions consistent with jaundice/anemia, high PRV loads and 
VDD state, but not diagnosed with jaundice/anemia, and high PRV loads, VDD state, and diagnosed with jaundice/anemia. Shown are the farm regions, year and quarter within which samples were collected and infectious agents detected (“cn/µg” =“copy 
number per
 
µg of nucleic acids”). The first three digits of the Farm codes indicate regions, with P.2 being farms on the west side of Vancouver Island and P.3 being farms on the east coast of Vancouver Island (Discovery Islands through Broughton (Fig. S1). 
Acronyms for the infectious agents are: P. sal=Piscirickettsia salmonis, R. sal=Renibacterium salmoninarum, A. sal=Aeromonas salmonicida, V. ang=Vibrio anguillarum, L. sal=Loma salmonae, D. lep=
 
Desmozoon lepeoptherii, P. pse=Parvicapsula 
pseudobranchicola 
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Table 3. Histopathology scoring across all tissues of Atlantic salmon over the developmental pathway of HSMI, and Chinook salmon over the developmental pathway of jaundice/anemia.  
 Atlantic salmon 
    Heart   Liver   Spleen   Kidney   Brain   Gills   Muscle     
Group 
Fish 
# 
Epi End   Nec Itis   Con 
Ell 
nec 
Wpu 
itis 
  Itis Osis 
Int 
pla 
Nec 
Glo 
itis 
  Gli Con   Itis Con Pro   Itis 
Original 
Diagnosis 
Co-infection 
agents 
2     
(PRV+/HSMI-) 
B5389 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B5760 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B5903 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B5940 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B7274 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B7283 0 0   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
3       
(Developing) 
B5392 2 1   0 0   0 0 1   0 0 0 0 0   0 0   0 0 0   0     
B5597 1 0.5   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B5910 1 0.5   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
B5933 2 1   0 0   0 0 1   0 0 1 0 0   0 0   1 0 0   2     
B5937 2 1   0 0   0 0 1   0 0 1 0 0   0 0   0 0 0   1     
B7273 2 1   0 0   0 0 0   0 0 0 0 0   0 0   0 0 0   0     
4                  
(HSMI) 
B5690 3 3   2 0   0 1 0   0 0 0 0 0   0 0   2 0 0   3 HSMI   
B5688 2 2   2 0   1 2 1   0 0 1 0 0   0 1   0 0 0   2 HSMI   
B7293 3 3   1 0   0 1 1   0 0 1 0 0   0 0   0 0 0   2 HSMI   
B7483 2 3   2 0   2 2 1   0 0 1 0 0   0 0   0 0 0   3 HSMI   
B7474 2 2   2 0   1 1 0   0 0 0 0 0   0 0   0 0 0   3 HSMI   
B7473 1 3   2 0   1 2 0   0 0 0 0 0   0 0   0 0 0   3 HSMI   
                                                        
Chinook salmon 
1                   
(PRV+) 
G572 0 0   0 0   0 0 0   0 0 1 0 0   0 0   0 0 0   0 nephrocalcinosis   
G939 0 0   0 0   0 0 0   0 0 2 0 0   0 0   1 0 1   0 branchitis P. pseudobranchicola 
G869 0 0   0 3   0 0 0   0 2 2 0 0   0 0   0 0 0   0 rickettsiosis P. salmonis 
2      
(PRV+/VDD+)  
G459 0 0   2 0   2 2 0   0 2 2 0 2   0 0   1 0 0   0 BKD R. salmoninarum 
G363 0 0   3 0   0 3 0   0 0 2 2 0   0 0   0 0 0   0 IHN-like? L. salmonae 
G772 0 0   2 0   1 1 1   0 1 3 0 0   1 0   0 0 0   0 rickettsiosis NO P. salmonis 
G722 0 0   0 2   0 0 2   0 0 0 0 0   0 0   0 0 0   0 vibriosis V. anguillarum 
G460 0 1   0 0   2 0 0   0 2 1 0 0   0 0   0 0 1   0 anemia   
3       
(PRV+/VDD+            
jaundice/     
anemia) 
G364 0 3   2 0   1 0 0   0 0 2 0 0   0 0   0 0 0   0 jaundice/anemia   
G579 0 0   2 0   0 3 3   2 0 3 0 0   0 0   0 0 0   0 jaundice ENV, L. salmonae 
G578 0 3   2 3   1 1 3   3 0 2 0 0   0 0   0 0 0   0 jaundice/anemia   
G481 0 0   0* 0   2 0 0   0 2 2 0 0   0 0   0 0 0   0 jaundice/anemia   
G417 0 0   0 0   0 0 2   2 0 0 0 0   0 0   2 0 0   0 jaundice/anemia L. salmonae 
G172 0 0   0 0   0 0 0   0 2 3 0 0   0 0   0 0 0   0 jaundice/anemia   
G563 0 0   1 0   1 2 0   1 0 2 0 0   0 0   0 0 0   0 jaundice   
G287 0 0   0* 0   0 0 2   0 0 2 0 0   1 0   0 3 0   0 jaundice   
G673 0 2   1 0   0 1 0   0 3 2 0 0   0 0   0 0 0   0 jaundice   
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Note: Lesion scores different than zero are highlighted in bold. Abbreviations for lesions are as follows: Epi=epicarditis, End=endocarditis, Con=congestion, Nec=necrosis, Itis=inflammation, Ell nec=ellipsoid necrosis, Wpu Itis=white pulp inflammation, 
Osis=tubule necrosis, Int pla=interstitial tissue hyperplasia, Glo Itis=glomeruli inflammation, Gli=gliosis, Pro=proliferation. Other lesions (i.e. liver congestion, spleen capsule proliferation, pancreatitis, enteritis, encephalitis, cerebral malacia and cerebral 
microsporidia) have been assessed, but did not occur in any fish, therefore have not been included in the table. Two fish (marked with*) had no necrotic areas in the liver, but virtually all hepatocytes had varying degrees of vacuolar degeneration, 
characterized by a foamy cytoplasm. 
 
